Linol; Julie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Linol; Julie.The latest application filed is for "solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate and polymorphs thereof".

Company Profile

0.9.12

Linol; Julie - Malaunay FR
Linol; Julie - Rouen FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process for the preparation of the L-arginine salt of perindopril Grant 8,865,915 - Linol , et al. October 21, 2	2014-10-21
Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it Grant 8,835,652 - Linol , et al. September 16, 2	2014-09-16
Solid Pharmaceutical Composition Containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl Sulfamate And Polymorphs Thereof App 20140056977 - MONDOLY; Nathalie ; et al.	2014-02-27
Delta Crystalline Form Of The Arginine Salt Of Perindopril, A Process For Its Preparation, And Pharmaceutical Compositions Containing It App 20130178464 - LINOL; Julie ; et al.	2013-07-11
Process For The Preparation Of The L-arginine Salt Of Perindopril App 20130178635 - Linol; Julie ; et al.	2013-07-11
Solid Pharmaceutical Composition Containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl Sulfamate And Polymorphs Thereof App 20120321714 - MONDOLY; Nathalie ; et al.	2012-12-20
Process for obtaining the crystalline form V of agomelatine Grant 8,252,957 - Martins , et al. August 28, 2	2012-08-28
Crystalline form VI of agomelatine, a process for its preparation and pharmaceutical compositions containing it Grant 8,067,639 - Coquerel , et al. November 29, 2	2011-11-29
Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it Grant 7,939,566 - Coquerel , et al. May 10, 2	2011-05-10
Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it Grant 7,910,625 - Coquerel , et al. March 22, 2	2011-03-22
Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it App 20100076088 - Coquerel; Gerard ; et al.	2010-03-25
Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it App 20100063158 - Coquerel; Gerard ; et al.	2010-03-11
Process for obtaining the crystalline form V of agomelatine App 20100036165 - Martins; Damien ; et al.	2010-02-11
Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it Grant 7,645,905 - Coquerel , et al. January 12, 2	2010-01-12
Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it Grant 7,635,721 - Coquerel , et al. December 22, 2	2009-12-22
Cystalline form VI of agomelatine, a process for its preparation and pharmaceutical compositions containing it App 20090069434 - Coquerel; Gerard ; et al.	2009-03-12
Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it Grant 7,358,395 - Coquerel , et al. April 15, 2	2008-04-15
Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it App 20060270877 - Coquerel; Gerard ; et al.	2006-11-30
Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it App 20060270876 - Coquerel; Gerard ; et al.	2006-11-30
Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it App 20060270875 - Coquerel; Gerard ; et al.	2006-11-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.